Genetic variation in the peroxisome proliferator-activated receptor (PPAR) and peroxisome proliferator-activated receptor gamma co-activator 1 (PGC1) gene families and type 2 diabetes

Annals of Human Genetics

Volumn 78, Issue 1, 2014, Pages 23-32

  Villegas, Raquel ^a   Williams, Scott M ^b   Gao, Yu Tang ^c   Long, Jirong ^a   Shi, Jiajun ^a   Cai, Hui ^a   Li, Honglan ^b   Chen, Ching Chu ^d   Tai, E Shyong ^e   Hu, Frank ^f   Cai, Qiuyin ^a   Zheng, Wei ^a   Shu, Xiao Ou ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c SHANGHAI CANCER INSTITUTE   (China)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^f HARVARD UNIVERSITY   (United States)

Author keywords

PGC1; PPAR; Type 2 diabetes

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; EXERCISE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIGENE FAMILY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

PGC1; PPAR; TYPE 2 DIABETES;

ADULT; AGED; BODY MASS INDEX; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHINA; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; GENE FREQUENCY; GENE-ENVIRONMENT INTERACTION; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84890840256     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/ahg.12044     Document Type: Article

References (53)

1. Ambye, L., Rasmussen, S., Fenger, M., Jorgensen, T., Borch-Johnsen, K., Madsbad, S., & Urhammer, S. A. (2005) Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome. Diabetes Res Clin Pract 67, 175-179.
2. Andersen, G., Wegner, L., Yanagisawa, K., Rose, C. S., Lin, J., Glumer, C., Drivsholm, T., Borch-Johnsen, K., Jorgensen, T., Hansen, T., Spiegelman, B. M., & Pedersen, O. (2005) Evidence of an association between genetic variation of the coactivator PGC-1beta and obesity. J Med Genet 42, 402-407.
3. Andrulionyte, L., Peltola, P., Chiasson, J. L., & Laakso, M. (2006) Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: The STOP-NIDDM trial. Diabetes 55, 2148-2152.
4. Barroso, I., Luan, J., Sandhu, M. S., Franks, P. W., Crowley, V., Schafer, A. J., O'Rahilly, S., & Wareham, N. J. (2006) Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia 49, 501-505.
5. Cai, H., Zheng, W., Xiang, Y. B., Xu, W. H., Yang, G., Li, H., & Shu, X. O. (2007) Dietary patterns and their correlates among middle-aged and elderly Chinese men: A report from the Shanghai Men's Health Study. Br J Nutr 98, 1006-1013.
6. Carey, V. J., Walters, E. E., Colditz, G. A., Solomon, C. G., Willett, W. C., Rosner, B. A., Speizer, F. E., & Manson, J. E. (1997) Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 145, 614-619.
7. Chan, J. M., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17, 961-969.
8. Colditz, G. A., Willett, W. C., Stampfer, M. J., Manson, J. E., Hennekens, C. H., Arky, R. A., & Speizer, F. E. (1990) Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 132, 501-513.
9. Esterbauer, H., Oberkofler, H., Krempler, F., & Patsch, W. (1999) Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics 62, 98-102.
10. Evans, D., Aberle, J., Wendt, D., Wolf, A., Beisiegel, U., & Mann, W. A. (2001) A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus. J Mol Med 79, 198-204.
11. Flavell, D. M., Ireland, H., Stephens, J. W., Hawe, E., Acharya, J., Mather, H., Hurel, S. J., & Humphries, S. E. (2005) Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes. Diabetes 54, 582-586.
12. Gregg, E. W., Cadwell, B. L., Cheng, Y. J., Cowie, C. C., Williams, D. E., Geiss, L., Engelgau, M. M., & Vinicor, F. (2004) Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes Care 27, 2806-2812.
13. Guo, W.L., Tang, Y., Han, X. Y., & Ji, L. N. (2011) Meta-analysis of the association of Pro12Ala polymorphism of peroxisome proliferator activated receptor gamma gene with type 2 diabetes in Chinese Han population. Zhongguo Yi Xue Ke Xue Yuan Xue. Bao 33, 593-599.
14. Helmrich, S. P., Ragland, D. R., Leung, R. W., & Paffenbarger, R. S., Jr. (1991) Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325, 147-152.
15. Hu, C., Jia, W., Fang, Q., Zhang, R., Wang, C., Lu, J., & Xiang, K. (2006) Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects. Diabet Med 23, 1307-1312.
16. Hu, F. B., Leitzmann, M. F., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Rimm, E. B. (2001a) Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 161, 1542-1548.
17. Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001b) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345, 790-797.
18. King, H., Aubert, R. E., & Herman, W. H. (1998) Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 21, 1414-1431.
19. King, H. & Rewers, M. (1993) Diabetes in adults is now a Third World problem. World Health Organization Ad Hoc Diabetes Reporting Group. Ethn Dis 3, (Suppl) 67-74.
20. Kunej, T., Globocnik, P. M., Dovc, P., Peterlin, B., & Petrovic, D. (2004) A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians. Folia Biol.(Praha) 50, 157-158.
21. Lin, J., Handschin, C., & Spiegelman, B. M. (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1, 361-370.
22. Lu, L., Wu, Y., Qi, Q., Liu, C., Gan, W., Zhu, J., Li, H., & Lin, X. (2012) Associations of type 2 diabetes with common variants in PPARD and the modifying effect of vitamin D among middle-aged and elderly Chinese. PLoS One 7, e34895.
23. Manson, J. E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Willett, W. C., Krolewski, A. S., Rosner, B., Hennekens, C. H., & Speizer, F. E. (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338, 774-778.
24. Matthews, C. E., Shu, X. O., Jin, F., Dai, Q., Hebert, J. R., Ruan, Z. X., Gao, Y. T., & Zheng, W. (2001) Lifetime physical activity and breast cancer risk in the Shanghai Breast Cancer Study. Br J Cancer 84, 994-1001.
25. Matthews, C. E., Shu, X.O., Yang, G., Jin, F., Ainsworth, B. E., Liu, D., Gao, Y. T., & Zheng, W. (2003) Reproducibility and validity of the Shanghai Women's Health Study physical activity questionnaire. Am J Epidemiol 158, 1114-1122.
26. Medina-Gomez, G., Gray, S., & Vidal-Puig, A. (2007) Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1). Public Health Nutr 10, 1132-1137.
27. Nelson, T. L., Fingerlin, T. E., Moss, L., Barmada, M. M., Ferrell, R. E., & Norris, J. M. (2007) The peroxisome proliferator-activated receptor gamma coactivator-1 alpha gene (PGC-1alpha) is not associated with type 2 diabetes mellitus or body mass index among Hispanic and non Hispanic Whites from Colorado. Exp Clin Endocrinol Diabetes 115, 268-275.
28. Ohlson, L. O., Larsson, B., Svardsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Bjorntorp, P., & Tibblin, G. (1985) The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34, 1055-1058.
29. Park, K. S., Shin, H. D., Park, B. L., Cheong, H. S., Cho, Y. M., Lee, H. K., Lee, J. Y., Lee, J. K., Kim, H. T., Park, C. S., Han, B. G., Kimm, K., & Oh, B. (2006) Putative association of peroxisome proliferator-activated receptor gamma co-activator 1beta (PPARGC1B) polymorphism with Type 2 diabetes mellitus. Diabet Med 23, 635-642.
30. Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., Landaker, E. J., Goldfine, A. B., Mun, E., DeFronzo, R., Finlayson, J., Kahn, C. R., & Mandarino, L. J. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100, 8466-8471.
31. Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839.
32. Robitaille, J., Brouillette, C., Houde, A., Lemieux, S., Perusse, L., Tchernof, A., Gaudet, D., & Vohl, M. C. (2004) Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome. J Hum Genet 49, 482-489.
33. Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., Prokunina-Olsson, L., Ding, C. J., Swift, A. J., Narisu, N., Hu, T., Pruim, R., Xiao, R., Li, X. Y., Conneely, K. N., Riebow, N. L., Sprau, A. G., Tong, M., White, P. P., Hetrick, K. N., Barnhart, M. W., Bark, C. W., Goldstein, J. L., Watkins, L., Xiang, F., Saramies, J., Buchanan, T. A., Watanabe, R. M., Valle, T. T., Kinnunen, L., Abecasis, G. R., Pugh, E. W., Doheny, K. F., Bergman, R. N., Tuomilehto, J., Collins, F. S., & Boehnke, M. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-1345.
34. Shin, H. D., Park, B. L., Kim, L. H., Jung, H. S., Cho, Y. M., Moon, M. K., Park, Y. J., Lee, H. K., & Park, K. S. (2004) Genetic polymorphisms in peroxisome proliferator-activated receptor delta associated with obesity. Diabetes 53, 847-851.
35. Shu, X. O., Long, J., Cai, Q., Qi, L., Xiang, Y. B., Cho, Y. S., Tai, E. S., Li, X., Lin, X., Chow, W. H., Go, M. J., Seielstad, M., Bao, W., Li, H., Cornelis, M. C., Yu, K., Wen, W., Shi, J., Han, B. G., Sim, X. L., Liu, L., Qi, Q., Kim, H. L., Ng, D. P., Lee, J. Y., Kim, Y. J., Li, C., Gao, Y. T., Zheng, W., & Hu, F. B. (2010) Identification of new genetic risk variants for type 2 diabetes. PLoS Genet 6, e1001127. doi: 10.1371/journal.pgen.1001127.
36. Sigal, R. J., Kenny, G. P., Wasserman, D. H., & Castaneda-Sceppa, C. (2004) Physical activity/exercise and type 2 diabetes. Diabetes Care 27, 2518-2539.
37. Spiegelman, B. M. (2007) Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Novartis Found Symp 287, 60-63.
38. Stumvoll, M., Fritsche, A., t'Hart, L. M., Machann, J., Thamer, C., Tschritter, O., Van Haeften, T. W., Jacob, S., Dekker, J. M., Maassen, J. A., Machicao, F., Schick, F., Heine, R. J., & Haring, H. (2004) The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations. Exp Clin Endocrinol Diabetes 112, 253-257.
39. Sun, L., Yang, Z., Jin, F., Zhu, X. Q., Qu, Y. C., Shi, X. H., & Wang, L. (2006) The Gly482Ser variant of the PPARGC1 gene is associated with Type 2 diabetes mellitus in northern Chinese, especially men. Diabet Med 23, 1085-1092.
40. Tai, E. S., Corella, D., Demissie, S., Cupples, L. A., Coltell, O., Schaefer, E. J., Tucker, K. L., & Ordovas, J. M. (2005) Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. J Nutr 135, 397-403.
41. Tai, E. S., Demissie, S., Cupples, L. A., Corella, D., Wilson, P. W., Schaefer, E. J., & Ordovas, J. M. (2002) Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 22, 805-810.
42. Tonjes, A. & Stumvoll, M. (2007) The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk. Curr Opin Clin Nutr Metab Care 10, 410-414.
43. Uthurralt, J., Gordish-Dressman, H., Bradbury, M., Tesi-Rocha, C., Devaney, J., Harmon, B., Reeves, E. K., Brandoli, C., Hansen, B. C., Seip, R. L., Thompson, P. D., Price, T. B., Angelopoulos, T. J., Clarkson, P. M., Moyna, N. M., Pescatello, L. S., Visich, P. S., Zoeller, R. F., Gordon, P. M., & Hoffman, E. P. (2007) PPARalpha L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males. BMC Med Genet 8, 55. doi:10.1186/1471-2350-8-55.
44. Villegas, R., Williams, S., Gao, Y., Cai, Q., Li, H., Elasy, T., Cai, H., Edwards, T., Xiang, Y. B., Zheng, W., Long, J., & Ou, S. X. (2011) Peroxisome proliferator-activated receptor delta (PPARD) genetic variation and type 2 diabetes in middle-aged Chinese women. Ann Hum Genet 75, 621-629.
45. Vimaleswaran, K. S., Radha, V., Anjana, M., Deepa, R., Ghosh, S., Majumder, P. P., Rao, M. R., & Mohan, V. (2006) Effect of polymorphisms in the PPARGC1A gene on body fat in Asian Indians. Int J Obes (Lond), 30, 884-891.
46. Vimaleswaran, K. S., Radha, V., Ghosh, S., Majumder, P. P., Deepa, R., Babu, H. N., Rao, M. R., & Mohan, V. (2005) Peroxisome proliferator-activated receptor-gamma co-activator-1alpha (PGC-1alpha) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians. Diabet Med 22, 1516-1521.
47. Wang, F., Han, X. Y., Ren, Q., Zhang, X. Y., Han, L. C., Luo, Y. Y., Zhou, X. H., & Ji, L. N. (2009) Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population. Chin Med J (Engl) 122, 2477-2482.
48. Wang, Y. B., Yu, Y. C., Li, Z., Wang, C., Wang, J. Y., & Wu, G. T. (2005) Study on the relationship between polymorphisms of peroxisome proliferators-activated receptor-gamma coactivator-1alpha gene and type 2 diabetes in Shanghai Hans in China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22, 453-456.
49. Wei, M., Gibbons, L. W., Mitchell, T. L., Kampert, J. B., Lee, C. D., & Blair, S. N. (1999) The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann Intern Med 130, 89-96.
50. Zhang, S. L., Lu, W. S., Yan, L., Wu, M. C., Xu, M. T., Chen, L. H., & Cheng, H. (2007) Association between peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene polymorphisms and type 2 diabetes in southern Chinese population: Role of altered interaction with myocyte enhancer factor 2C. Chin Med J (Engl) 120, 1878-1885.
51. Zheng, W., Chow, W. H., Yang, G., Jin, F., Rothman, N., Blair, A., Li, H. L., Wen, W., Ji, B. T., Li, Q., Shu, X. O., & Gao, Y. T. (2005) The Shanghai Women's Health Study: Rationale, study design, and baseline characteristics. Am J Epidemiol 162, 1123-1131.
52. Zheng, W., Long, J., Gao, Y. T., Li, C., Zheng, Y., Xiang, Y. B., Wen, W., Levy, S., Deming, S. L., Haines, J. L., Gu, K., Fair, A. M., Cai, Q., Lu, W., & Shu, X. O. (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 41, 324-328.
53. Zhu, S., Liu, Y., Wang, X., Wu, X., Zhu, X., Li, J., Ma, J., Gu, H. F., & Liu, Y. (2009) Evaluation of the association between the PPARGC1A genetic polymorphisms and type 2 diabetes in Han Chinese population. Diabetes Res Clin Pract 86, 168-172.